SNT
Click for more information
9.09% 2.4¢ syntara limited

Key catalysts targeted for 2019/2020Boehringer Ingelheim...

  1. Blockbuster
    173 Posts.
    lightbulb Created with Sketch. 37
    clock Created with Sketch.
    07/11/19
    08:54
    Post #: 41289239
    Key catalysts targeted for 2019/2020


    Boehringer Ingelheim acquired AOC3 inhibitor to report clinical proof of concept

    Phase 2a NASH study in 114 patients for 3 months -last patient last visit complete.Phase 2a clinical trial result and commercial assessment to progress to Phase 2b due from BI -Q4 2019

    Phase 2a diabetic retinopathy study in 100 patients for 3 months ->50% recruited Clinical and commercial assessment due from BI -mid 2020

    LOXL2 anti fibrotic program

    Partnering process to conclude -H2 2019

    Mannitol Business (Aridol & Bronchitol) to turn profitable in 2020

    US -FDA to complete review H1 2020; if approved -launch milestone US$10m

    Sales growth in existing and new territories expected to continue

    do not advertise external links.au/upload/CKEditor/untitled%20folder%201/triple2.jpg
    PXS Price at posting: 19.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TBN Tamboran is developing the NT Beetaloo Basin. To get there, it's listing at $36/sh on the NYSE
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
2.4¢ 		Change
0.002(9.09%) 		Mkt cap ! $28.65M
Open High Low Value Volume
2.2¢ 2.5¢ 2.2¢ $12.04K 509.9K

Buyers (Bids)

No. Vol. Price($)
1 82668 2.3¢
 

Sellers (Offers)

Price($) Vol. No.
2.4¢ 100000 1
View Market Depth
Last trade - 15.57pm 28/06/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.